Safety and Efficacy of the 2.25-mm Sirolimus-Eluting Bx Velocity Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions: the SIRIUS 2.25 Trial

Jeffrey W. Moses; Eugenia Nikolsky; Roxana Mehran; Patrick A. Cambier; William B. Bachinsky; Fred Leya; Richard E. Kuntz; Jeffrey J. Popma; Patricia Schleckser; Hong Wang; Sidney A. Cohen; Martin B. Leon

doi:10.1016/J.AMJCARD.2006.06.047

Safety and Efficacy of the 2.25-mm Sirolimus-Eluting Bx Velocity Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions: the SIRIUS 2.25 Trial

Jeffrey W. Moses
, Eugenia Nikolsky
, Roxana Mehran
, Patrick A. Cambier
, William B. Bachinsky
, Fred Leya
, Richard E. Kuntz
, Jeffrey J. Popma
, Patricia Schleckser
, Hong Wang
, Sidney A. Cohen
, Martin B. Leon

Columbia University Medical Center
Morton Plant Hospital
Harrisburg Hospital
Loyola University Medical Center
Brigham and Women's Hospital
Cordis

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	American Journal of Cardiology
Volume	98
Issue number	11
DOIs	https://doi.org/10.1016/J.AMJCARD.2006.06.047
State	Published - Dec 1 2006
Externally published	Yes

Disciplines

Medicine and Health Sciences
Cardiology
Internal Medicine

Access to Document

10.1016/J.AMJCARD.2006.06.047License: Unspecified

Cite this

Moses, J. W., Nikolsky, E., Mehran, R., Cambier, P. A., Bachinsky, W. B., Leya, F., Kuntz, R. E., Popma, J. J., Schleckser, P., Wang, H., Cohen, S. A., & Leon, M. B. (2006). Safety and Efficacy of the 2.25-mm Sirolimus-Eluting Bx Velocity Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions: the SIRIUS 2.25 Trial. American Journal of Cardiology, 98(11). https://doi.org/10.1016/J.AMJCARD.2006.06.047

Moses, JW, Nikolsky, E, Mehran, R, Cambier, PA, Bachinsky, WB, Leya, F, Kuntz, RE, Popma, JJ, Schleckser, P, Wang, H, Cohen, SA & Leon, MB 2006, 'Safety and Efficacy of the 2.25-mm Sirolimus-Eluting Bx Velocity Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions: the SIRIUS 2.25 Trial', American Journal of Cardiology, vol. 98, no. 11. https://doi.org/10.1016/J.AMJCARD.2006.06.047

@article{586d4192a0674683af87ea957696df0b,

title = "Safety and Efficacy of the 2.25-mm Sirolimus-Eluting Bx Velocity Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions: the SIRIUS 2.25 Trial",

author = "Moses, \{Jeffrey W.\} and Eugenia Nikolsky and Roxana Mehran and Cambier, \{Patrick A.\} and Bachinsky, \{William B.\} and Fred Leya and Kuntz, \{Richard E.\} and Popma, \{Jeffrey J.\} and Patricia Schleckser and Hong Wang and Cohen, \{Sidney A.\} and Leon, \{Martin B.\}",

note = "Smaller reference vessel diameter is a recognized determinant of in-stent restenosis. The SIRIUS 2.25 trial was a prospective, nonrandomized study including 100 patients (mean age 63.4 years; 64\% men, 40\% with diabetes mellitus) assessing the safety and efficacy of the 2.25-mm sirolimus-eluting Bx V ...",

year = "2006",

month = dec,

day = "1",

doi = "10.1016/J.AMJCARD.2006.06.047",

language = "American English",

volume = "98",

journal = "American Journal of Cardiology",

issn = "1879-1913",

number = "11",

}

TY - JOUR

T1 - Safety and Efficacy of the 2.25-mm Sirolimus-Eluting Bx Velocity Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions: the SIRIUS 2.25 Trial

AU - Moses, Jeffrey W.

AU - Nikolsky, Eugenia

AU - Mehran, Roxana

AU - Cambier, Patrick A.

AU - Bachinsky, William B.

AU - Leya, Fred

AU - Kuntz, Richard E.

AU - Popma, Jeffrey J.

AU - Schleckser, Patricia

AU - Wang, Hong

AU - Cohen, Sidney A.

AU - Leon, Martin B.

N1 - Smaller reference vessel diameter is a recognized determinant of in-stent restenosis. The SIRIUS 2.25 trial was a prospective, nonrandomized study including 100 patients (mean age 63.4 years; 64% men, 40% with diabetes mellitus) assessing the safety and efficacy of the 2.25-mm sirolimus-eluting Bx V ...

PY - 2006/12/1

Y1 - 2006/12/1

UR - https://www.ncbi.nlm.nih.gov/pubmed/17126649

U2 - 10.1016/J.AMJCARD.2006.06.047

DO - 10.1016/J.AMJCARD.2006.06.047

M3 - Article

SN - 1879-1913

VL - 98

JO - American Journal of Cardiology

JF - American Journal of Cardiology

IS - 11

ER -

Safety and Efficacy of the 2.25-mm Sirolimus-Eluting Bx Velocity Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions: the SIRIUS 2.25 Trial

Disciplines

Access to Document

Other files and links

Cite this